BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8774105)

  • 1. Sonographic characteristics of adenofibroma of the endometrium following tamoxifen therapy for breast cancer: two case reports.
    Huang KT; Chen CA; Cheng WF; Wu CC; Jou HJ; Hsieh CY; Lin GJ; Hsieh FJ
    Ultrasound Obstet Gynecol; 1996 May; 7(5):363-6. PubMed ID: 8774105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study.
    Achiron R; Lipitz S; Sivan E; Goldenberg M; Horovitz A; Frenkel Y; Mashiach S
    Ultrasound Obstet Gynecol; 1995 Aug; 6(2):116-20. PubMed ID: 8535913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenofibroma of the endometrium after tamoxifen therapy for breast cancer: MR findings.
    Oshima H; Miyagawa H; Sato Y; Satake M; Shiraki N; Nishikawa H; Arakawa A; Ogino H; Hara M
    Abdom Imaging; 2002; 27(5):592-4. PubMed ID: 12173004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary.
    Shi H; Chen X; Lv B; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):15381-5. PubMed ID: 26823898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound, tamoxifen and endometrial carcinoma.
    Ghirardini G; Bianchini A; Rossi GP
    Ultrasound Obstet Gynecol; 1999 May; 13(5):375-6. PubMed ID: 10380310
    [No Abstract]   [Full Text] [Related]  

  • 6. [Uterine pathology in women with breast cancer treated with tamoxifen].
    Carcangiu ML
    Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
    [No Abstract]   [Full Text] [Related]  

  • 7. Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings.
    Hann LE; Giess CS; Bach AM; Tao Y; Baum HJ; Barakat RR
    AJR Am J Roentgenol; 1997 Mar; 168(3):657-61. PubMed ID: 9057510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study.
    Exacoustos C; Zupi E; Cangi B; Chiaretti M; Arduini D; Romanini C
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):435-42. PubMed ID: 8903921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.
    Cohen I; Altaras MM; Tepper R; Beyth Y
    Gynecol Oncol; 1996 Dec; 63(3):412-4. PubMed ID: 8946882
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer.
    Barakat RR
    J Clin Oncol; 1999 Jul; 17(7):1967-8. PubMed ID: 10561245
    [No Abstract]   [Full Text] [Related]  

  • 11. The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen.
    Kazerooni T; Ghaffarpasand F; Mosalaei A; Kazerooni Y
    Med Princ Pract; 2010; 19(3):222-7. PubMed ID: 20357508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endometrium in breast cancer patients on tamoxifen.
    Dallenbach-Hellweg G; Schmidt D; Hellberg P; Bourne T; Kreuzwieser E; Dören M; Rydh W; Rudenstam G; Granberg S
    Arch Gynecol Obstet; 2000 Apr; 263(4):170-7. PubMed ID: 10834325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade endometrial stromal sarcoma following tamoxifen treatment.
    Engin H
    Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
    [No Abstract]   [Full Text] [Related]  

  • 14. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G; Hahn U; Schmidt D
    Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen and the uterus: an old drug tested by new modalities.
    Achiron R; Grisaru D; Golan-Porat N; Lipitz S
    Ultrasound Obstet Gynecol; 1996 May; 7(5):374-8. PubMed ID: 8774108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonographic follow-up in tamoxifene patients.
    Del Priore G
    Gynecol Oncol; 2000 Mar; 76(3):423-4. PubMed ID: 10684723
    [No Abstract]   [Full Text] [Related]  

  • 17. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 18. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma.
    Jagavkar RS; Shakespeare TP; Stevens MJ
    Australas Radiol; 1998 May; 42(2):157-8. PubMed ID: 9599835
    [No Abstract]   [Full Text] [Related]  

  • 19. Gynecologic surveillance of women on tamoxifen: first do no harm.
    Runowicz CD
    J Clin Oncol; 2000 Oct; 18(20):3457-8. PubMed ID: 11032584
    [No Abstract]   [Full Text] [Related]  

  • 20. Tamoxifen-induced endometrial polyp. A case report and review of the literature.
    Nomikos IN; Elemenoglou J; Papatheophanis J
    Eur J Gynaecol Oncol; 1998; 19(5):476-8. PubMed ID: 9863916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.